No Data
No Data
Agios to Webcast Conference Call of Second Quarter 2024 Financial Results on August 1, 2024
CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will
Form 144 | Agios Pharmaceuticals(AGIO.US) Officer Proposes to Sell 162.46K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Agios Pharmaceuticals(AGIO.US)$ Officer Gheuens Sarah intends to sell 3,705 shares of its common stock on Jul 1, with a total market value of approximately $162.46K.
Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA
Agios Pharmaceuticals (AGIO) Surges 6.5%: Is This an Indication of Further Gains?
Expert Ratings For Agios Pharmaceuticals
Agios Pharmaceuticals (NASDAQ:AGIO) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below provides a concise overv
Cantor Fitzgerald Reiterates Overweight on Agios Pharmaceuticals
Cantor Fitzgerald analyst Eric Schmidt reiterates Agios Pharmaceuticals (NASDAQ:AGIO) with a Overweight.